JohnJosephWallbillichIVMD
Obstetrics & Gynecology • Detroit, MIGynecologic Oncology
Assistant Professor, Gynecologic Oncology, Karmanos Cancer Institute
Dr. Wallbillich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Karmanos Cancer Center
4100 John R St
Detroit, MI 48201Phone+1 800-527-6266
Education & Training
Medical College of Georgia at Augusta UniversityPost-Doctoral Fellowship, 2016 - 2019
Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2013 - 2016
University of Texas Health Science Center at HoustonResidency, Obstetrics and Gynecology, 2009 - 2013
University of Michigan Medical SchoolClass of 2009
Certifications & Licensure
MI State Medical License 2019 - 2025
GA State Medical License 2016 - 2019
OH State Medical License 2013 - 2017- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- GCC Superhero Award Georgia Cancer Center at Augusta University, 2019
Clinical Trials
Publications & Presentations
PubMed
- 196 citationsHypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteinsKalpana Deepa Priya Dorayappan, Ross Wanner, John J. Wallbillich, Uksha Saini, Roman A. Zingarelli
Oncogene. 2018-04-11 - 27 citationsHigh Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.John J. Wallbillich, Srirama Josyula, Uksha Saini, Roman A. Zingarelli, Kalpana Deepa Priya Dorayappan
Plos One. 2017-01-23 - 12 citationsComparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination defic...John J. Wallbillich, Robert T. Morris, Rouba Ali-Fehmi
Gynecologic Oncology. 2020-11-01
Journal Articles
- Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovaryJohn J. Wallbillich, Alpa M. Nick, Pedro T. Ramirez, Jack L. Watkins, Elizabeth D. Euscher, Kathleen M. Schmeler, Gynecologic Oncology Case Reports
Abstracts/Posters
- Clinical Practice Guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies.Meyer L, Schmeler K, Wallbillich J, Urbauer D, Soliman P, Frumovitz M, Burke C, Bodurka D, Levenback C, The Society for Gynecologic Oncology Annual Meeting on Women’s Cancer; Orlando, FL., 3/1/2011
- Clinical Practice Guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies.Meyer L, Schmeler K, Wallbillich J, Urbauer D, Soliman P, Frumovitz M, Burke C, Bodurka D, Levenback C, Gynecologic Oncology, 1/1/2011
- The Proper Pap: Reducing the Overutilization of Pap Test for Disease Surveillance in Survivors of Gynecologic Malignancies.Meyer L, Levenback C, Wallbillich J, Garcia E, Urbauer D, Soliman P, Frumovitz M, Burke C, Schmeler K, University of Texas System Clinical Safety and Effectiveness Conference; Austin, TX., 11/1/2010
- Join now to see all
Press Mentions
McLaren Flint Expands Gynecologic Oncology CareAugust 27th, 2021- How Faith, Family and Commitment to Giving to Others Help a Four-Time Cancer Survivor in the Fight for Her LifeAugust 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
